Management Comment Commenting on the announcement, Dr. Jim Phillips, CEO of Midatech Pharma, said: "We are pleased to complete the acquisition of Zuplenz®, which adds to our rapidly growing portfolio of marketed oncology products. We believe that our recent product acquisitions will help drive the Group towards sustainable profitability."